Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Adding aripiprazole to the treatment improved hair-pulling symptoms in a teenager.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

The Accu-Chek FlexLink Plus and Accu-Chek LinkAssist Plus make insulin pump use safer, simpler, and more comfortable.

Recognizing IPPP is crucial to prevent misdiagnosis and unnecessary treatments.

Scalp rolling might help regrow hair in people with a hair loss condition called Alopecia Areata.

HPDAlR nanoparticles greatly improve skin wound healing without toxicity.

A girl with Pitt-Hopkins syndrome developed curly hair as a rare side effect from the epilepsy drug perampanel.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

New technologies improve diagnosis and treatment of digestive disorders.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

The new assay can help develop products for hair re-growth.

Agmatine may help reduce seizures linked to hormone changes in female rats.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.

Analog 23 is a promising compound for prostate cancer treatment.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

The new palladium catalyst is effective and reusable for making pharmaceutical ingredients.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.